Skip to main content

Table 1 Baseline patient characteristics of the colorectal cancer cohort (n = 550,325)

From: Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria

Patient Characteristics

All patients No.

Prior malignancy No. (%)+

No prior malignancy No. (%)+

Age

 < 20

319

2 (0.6)

317 (99.4)

 20–65

190507

5091 (2.7)

185416 (97.3)

 > 65

359499

26570 (7.4)

332929 (92.6)

Sex

 Male

271959

17535 (6.4)

254424 (93.6)

 Female

278366

14128 (5.1)

264238 (94.9)

Site

 Rectum

161326

8224 (5.1)

153102 (94.9)

 Colon

388999

23439 (6)

365560 (94.0)

Race

 White

458185

27267 (6)

430918 (94.0)

 Black

52918

2845 (5.4)

50073 (94.6)

 Others

36920

1538 (4.2)

35382 (95.8)

Marital Status

 Single

57126

2470 (4.3)

54656 (95.7)

 Married

299526

17787 (5.9)

281739 (94.1)

 Separated

8217

282 (3.4)

7935 (96.6)

 Divorced

37197

1891 (5.1)

35306 (94.9)

 Widowed

126147

8086 (6.4)

118061 (93.6)

Stage

 Localized

199159

12848 (6.5)

186311 (93.5)

 Regional

197018

10884 (5.5)

186134 (94.5)

 Distant

119763

5980 (5)

113783 (95.0)

Grade

 Well differentiated

53999

3032 (5.6)

50967 (94.4)

 Moderately differentiated

288514

17377 (6)

271137 (94.0)

 Poorly differentiated

88748

5470 (6.2)

83278 (93.8)

 Undifferentiated, Anaplastic

5936

374 (6.3)

5562 (93.7)

Histology recode broad groupings

 Adenomas and adenocarcinomas

465847

26782 (5.7)

439065 (94.3)

 Cystic, mucinous and serous neoplasms

55884

3426 (6.1)

52458 (93.9)

 Epithelial neoplasms, NOS

18108

925 (5.1)

17183 (94.9)

 Squamous cell neoplasms

1815

118 (6.5)

1697 (93.5)

Radiation

 Yes

61226

2381 (3.9)

58845 (96.1)

 No

482430

29039 (6)

453391 (94.0)

Surgery

 Yes

467713

26940 (5.8)

440773 (94.2)

 No

60051

4020 (6.7)

56031 (93.3)

 Ablation

807

61 (7.6)

746 (92.4)

  1. +This number represents the percentage of patients with a prior malignancy within each characteristic